Drug Type Exosomes |
Synonyms Exosomes derived from mesenchymal stem cells(The Foundation For Regenerative Medicine), Mesenchymal Cell Exosome(The Foundation For Regenerative Medicine) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myasthenic Syndromes, Congenital | Phase 1 | United States | 01 Jan 2025 | |
| Myasthenic Syndromes, Congenital | Phase 1 | Antigua and Barbuda | 01 Jan 2025 | |
| Amyotrophic Lateral Sclerosis | Phase 1 | Antigua and Barbuda | 14 Jul 2024 | |
| Motor Disorders | Phase 1 | Antigua and Barbuda | 14 Jul 2024 |





